Trial intelligence / Profile preview

The SITE Study: Dextenza Insertion Timing in Cataract Surgery

NCT05100186Phase 4Unknown

Start
Nov 2021
Primary completion
Dec 2021
Modality
Implantable Devices, Implantable Hydrogels, Small Molecules
01

Overview

A Phase 4 trial of ozurdex in cataract. Status: unknown.

02

Drugs

ozurdex
03

Conditions

cataract

Beyond the preview

Go deeper on NCT05100186.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05100186.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call